Annual revenue:
$393.59M+$104.84M(+36.31%)Summary
- As of today (May 7, 2025), ASND annual revenue is $393.59 million, with the most recent change of +$104.84 million (+36.31%) on December 31, 2024.
- During the last 3 years, ASND annual revenue has risen by +$384.38 million (+4176.81%).
- ASND annual revenue is now at all-time high.
Performance
ASND Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly revenue:
$106.23M-$79.16M(-42.70%)Summary
- As of today (May 7, 2025), ASND quarterly revenue is $106.23 million, with the most recent change of -$79.16 million (-42.70%) on March 31, 2025.
- Over the past year, ASND quarterly revenue has increased by +$2.07 million (+1.98%).
- ASND quarterly revenue is now -42.70% below its all-time high of $185.39 million, reached on December 31, 2024.
Performance
ASND Quarterly revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM revenue:
$393.98M+$2.07M(+0.53%)Summary
- As of today (May 7, 2025), ASND TTM revenue is $393.98 million, with the most recent change of +$2.07 million (+0.53%) on March 31, 2025.
- Over the past year, ASND TTM revenue has increased by +$37.55 million (+10.53%).
- ASND TTM revenue is now at all-time high.
Performance
ASND TTM revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ASND Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +36.3% | +2.0% | +10.5% |
| 3 y3 years | +4176.8% | +1286.5% | +2392.5% |
| 5 y5 years | +2528.6% | +4226.3% | +3376.5% |
ASND Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +4176.8% | -42.7% | +1518.9% | at high | +2392.5% |
| 5 y | 5-year | at high | +4856.7% | -42.7% | >+9999.0% | at high | +9554.5% |
| alltime | all time | at high | >+9999.0% | -42.7% | >+9999.0% | at high | >+9999.0% |
Ascendis Pharma A/S Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $106.23M(-42.7%) | $393.98M(+0.5%) |
| Dec 2024 | $393.59M(+36.3%) | $185.39M(+191.5%) | $391.91M(+10.5%) |
| Sep 2024 | - | $63.61M(+64.1%) | $354.82M(+3.3%) |
| Jun 2024 | - | $38.76M(-62.8%) | $343.51M(-3.6%) |
| Mar 2024 | - | $104.16M(-29.8%) | $356.43M(+23.6%) |
| Dec 2023 | $288.75M(+435.0%) | $148.29M(+183.5%) | $288.35M(+76.4%) |
| Sep 2023 | - | $52.30M(+1.2%) | $163.47M(+29.2%) |
| Jun 2023 | - | $51.68M(+43.3%) | $126.57M(+55.4%) |
| Mar 2023 | - | $36.08M(+54.1%) | $81.45M(+53.6%) |
| Dec 2022 | $53.97M(+486.4%) | $23.41M(+52.0%) | $53.04M(+50.6%) |
| Sep 2022 | - | $15.40M(+134.7%) | $35.23M(+66.7%) |
| Jun 2022 | - | $6.56M(-14.4%) | $21.14M(+33.7%) |
| Mar 2022 | - | $7.66M(+36.8%) | $15.81M(+74.8%) |
| Dec 2021 | $9.20M(+15.9%) | $5.60M(+326.8%) | $9.04M(+121.6%) |
| Sep 2021 | - | $1.31M(+6.5%) | $4.08M(-31.9%) |
| Jun 2021 | - | $1.23M(+37.0%) | $5.99M(-5.5%) |
| Mar 2021 | - | $898.90K(+40.9%) | $6.34M(-19.7%) |
| Dec 2020 | $7.94M(-47.0%) | $637.90K(-80.2%) | $7.90M(-21.3%) |
| Sep 2020 | - | $3.22M(+103.9%) | $10.04M(+7.8%) |
| Jun 2020 | - | $1.58M(-35.6%) | $9.31M(-17.9%) |
| Mar 2020 | - | $2.46M(-11.6%) | $11.33M(-24.6%) |
| Dec 2019 | $14.97M | $2.78M(+11.3%) | $15.03M(-38.0%) |
| Sep 2019 | - | $2.49M(-30.9%) | $24.25M(+11.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | $3.61M(-41.3%) | $21.78M(+19.7%) |
| Mar 2019 | - | $6.15M(-48.7%) | $18.19M(+50.6%) |
| Dec 2018 | $12.49M(+621.1%) | $12.00M(>+9900.0%) | $12.08M(+2853.4%) |
| Sep 2018 | - | $23.30K(+8.4%) | $408.90K(-54.4%) |
| Jun 2018 | - | $21.50K(-37.5%) | $895.80K(-34.3%) |
| Mar 2018 | - | $34.40K(-89.6%) | $1.36M(-21.0%) |
| Dec 2017 | $1.73M(-66.0%) | $329.70K(-35.4%) | $1.72M(-31.6%) |
| Sep 2017 | - | $510.20K(+4.4%) | $2.52M(-24.0%) |
| Jun 2017 | - | $488.50K(+23.3%) | $3.31M(-19.3%) |
| Mar 2017 | - | $396.30K(-64.8%) | $4.11M(-19.4%) |
| Dec 2016 | $5.10M(-43.4%) | $1.13M(-13.8%) | $5.10M(-16.9%) |
| Sep 2016 | - | $1.30M(+1.7%) | $6.14M(-14.6%) |
| Jun 2016 | - | $1.28M(-7.5%) | $7.19M(-10.7%) |
| Mar 2016 | - | $1.39M(-35.8%) | $8.05M(-10.7%) |
| Dec 2015 | $9.01M(-51.6%) | $2.16M(-8.1%) | $9.01M(-13.2%) |
| Sep 2015 | - | $2.35M(+9.6%) | $10.38M(-15.8%) |
| Jun 2015 | - | $2.15M(-8.6%) | $12.33M(-20.7%) |
| Mar 2015 | - | $2.35M(-33.5%) | $15.55M(-16.7%) |
| Dec 2014 | $18.60M(-31.4%) | $3.53M(-18.1%) | $18.68M(-17.8%) |
| Sep 2014 | - | $4.31M(-19.7%) | $22.71M(+23.4%) |
| Jun 2014 | - | $5.37M(-1.9%) | $18.41M(+41.2%) |
| Mar 2014 | - | $5.47M(-27.7%) | $13.04M(+72.3%) |
| Dec 2013 | $27.10M(+35.3%) | $7.57M | $7.57M |
| Dec 2012 | $20.03M | - | - |
FAQ
- What is Ascendis Pharma A/S annual revenue?
- What is the all time high annual revenue for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S annual revenue year-on-year change?
- What is Ascendis Pharma A/S quarterly revenue?
- What is the all time high quarterly revenue for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S quarterly revenue year-on-year change?
- What is Ascendis Pharma A/S TTM revenue?
- What is the all time high TTM revenue for Ascendis Pharma A/S?
- What is Ascendis Pharma A/S TTM revenue year-on-year change?
What is Ascendis Pharma A/S annual revenue?
The current annual revenue of ASND is $393.59M
What is the all time high annual revenue for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high annual revenue is $393.59M
What is Ascendis Pharma A/S annual revenue year-on-year change?
Over the past year, ASND annual revenue has changed by +$104.84M (+36.31%)
What is Ascendis Pharma A/S quarterly revenue?
The current quarterly revenue of ASND is $106.23M
What is the all time high quarterly revenue for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high quarterly revenue is $185.39M
What is Ascendis Pharma A/S quarterly revenue year-on-year change?
Over the past year, ASND quarterly revenue has changed by +$2.07M (+1.98%)
What is Ascendis Pharma A/S TTM revenue?
The current TTM revenue of ASND is $393.98M
What is the all time high TTM revenue for Ascendis Pharma A/S?
Ascendis Pharma A/S all-time high TTM revenue is $393.98M
What is Ascendis Pharma A/S TTM revenue year-on-year change?
Over the past year, ASND TTM revenue has changed by +$37.55M (+10.53%)